Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Long-term survival of mechanically ventilated patients with severe COVID-19, an observational cohort study

  • Peñuelas, Oscar|||0000-0003-1484-3933
  • del Campo-Albendea, Laura|||0000-0002-1940-4932
  • Lesmes González de Aledo, Amanda|||0000-0001-8397-4844
  • Añón, José Manuel
  • Rodríguez-Solís, Carmen
  • Mancebo Cortes, Jordi|||0000-0003-3308-5410
  • Vera Artazcoz, Paula|||0000-0003-3346-5093
  • Ballesteros Orozco, Daniel
  • Jiménez, Jorge
  • Maseda, Emilio|||0000-0003-2898-7073
  • Figueira, Juan Carlos
  • Franco, Nieves
  • Algaba, Ángela
  • Avilés, Juan Pablo
  • Díaz, Ricardo
  • Abad, Beatriz
  • Canabal, Alfonso|||0000-0001-7021-3456
  • Abella, Ana
  • Gordo Vidal, Federico|||0000-0001-9605-1918
  • García, Javier
  • García Suarez, Jessica
  • Cedeño, Jamil
  • Martínez-Palacios, Basilia
  • Manteiga, Eva
  • Martínez, Óscar|||0000-0003-0263-4333
  • Blancas, Rafael|||0000-0002-7559-710X
  • Bardi, Tommaso
  • Pestaña, David
  • Lorente, Jose Ángel
  • Muriel, Alfonso|||0000-0002-4805-4011
  • Esteban, Andrés|||0000-0002-0146-3328
  • Frutos-Vivar, Fernando
Background: Information is lacking regarding long-term survival and predictive factors for mortality in patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19) and undergoing invasive mechanical ventilation. We aimed to estimate 180-day mortality of patients with COVID-19 requiring invasive ventilation, and to develop a predictive model for long-term mortality. Methods: Retrospective, multicentre, national cohort study between March 8 and April 30, 2020 in 16 intensive care units (ICU) in Spain. Participants were consecutive adults who received invasive mechanical ventilation for COVID-19. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection detected in positive testing of a nasopharyngeal sample and confirmed by real time reverse-transcriptase polymerase chain reaction (rt-PCR). The primary outcomes was 180-day survival after hospital admission. Secondary outcomes were length of ICU and hospital stay, and ICU and in-hospital mortality. A predictive model was developed to estimate the probability of 180-day mortality. Results: 868 patients were included (median age, 64 years [interquartile range [IQR], 56-71 years]; 72% male). Severity at ICU admission, estimated by SAPS3, was 56 points [IQR 50-63]. Prior to intubation, 26% received some type of noninvasive respiratory support. The unadjusted overall 180-day survival rates was 59% (95% CI 56-62%). The predictive factors measured during ICU stay, and associated with 180-day mortality were: age [Odds Ratio [OR] per 1-year increase 1.051, 95% CI 1.033-1.068)), SAPS3 (OR per 1-point increase 1.027, 95% CI 1.011-1.044), diabetes (OR 1.546, 95% CI 1.085-2.204), neutrophils to lymphocytes ratio (OR per 1-unit increase 1.008, 95% CI 1.001-1.016), failed attempt of noninvasive positive pressure ventilation prior to orotracheal intubation (OR 1.878 (95% CI 1.124-3.140), use of selective digestive decontamination strategy during ICU stay (OR 0.590 (95% CI 0.358-0.972) and administration of low dosage of corticosteroids (methylprednisolone 1 mg/kg) (OR 2.042 (95% CI 1.205-3.460). Conclusion: The long-term survival of mechanically ventilated patients with severe COVID-19 reaches more than 50% and may help to provide individualized risk stratification and potential treatments. Trial registration: ClinicalTrials.gov Identifier: NCT04379258. Registered 10 April 2020 (retrospectively registered).